EndoStim Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

EndoStim General Information

Description

Developer of an implantable neurostimulation device designed to treat gastroesophageal reflux disease through electrical stimulation of the lower esophageal sphincter. The company offers a first-in-class implantable system that automatically delivers mild electrical signals throughout the day to the lower esophageal sphincter muscle, restoring function to the weakened valve between the esophagus and stomach without relying on pharmaceutical intervention, enabling patients to reduce or avoid typical gastrointestinal side effects of traditional anti-reflux surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4101 McEwen
  • Suite 336
  • Dallas, TX 75244
  • United States
+1 (469)
Primary Industry
Therapeutic Devices
Corporate Office
  • 4101 McEwen
  • Suite 336
  • Dallas, TX 75244
  • United States
+1 (469)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoStim Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-Dec-2025 Completed Generating Revenue
9. Later Stage VC 01-Aug-2019 Completed Generating Revenue
8. Later Stage VC 12-Jan-2018 Completed Generating Revenue
7. Later Stage VC (Series D) 01-Mar-2016 Completed Generating Revenue
6. IPO 09-Dec-2015 Cancelled Generating Revenue
5. Later Stage VC (Series C1) 01-May-2015 Completed Generating Revenue
4. Later Stage VC (Series C) 29-May-2013 Completed Startup
3. Early Stage VC (Series B1) 01-Nov-2011 Completed Startup
2. Early Stage VC (Series B) 13-Jul-2010 $6M $7.5M Completed Startup
1. Early Stage VC (Series A) 30-Sep-2009 $1.5M $1.5M Completed Startup
To view EndoStim’s complete valuation and funding history, request access »

EndoStim Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D3
Series D2
Series D1
Series D
Series C1
Series C
Series B1
Series B 1,119,317 $0.001000 8% $5 $5 $3.13 5.96%
Series A 195,452 $0.001000 8% $3.33 $3.33 $2.63 0.82%
To view EndoStim’s complete cap table history, request access »

EndoStim Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an implantable neurostimulation device designed to treat gastroesophageal reflux disease through electrical
Therapeutic Devices
Dallas, TX
4 As of 2026

Tirat Carmel, Israel
 

Fort Lauderdale, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EndoStim Competitors (12)

One of EndoStim’s 12 competitors is Insightec, a Venture Capital-Backed company based in Tirat Carmel, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Insightec Venture Capital-Backed Tirat Carmel, Israel
Spatz (Therapeutic Devices) Venture Capital-Backed Fort Lauderdale, FL
Morphic Medical Private Equity-Backed Boston, MA
EndoGastric Solutions Formerly VC-backed Redmond, WA
USGI Medical Venture Capital-Backed San Clemente, CA
You’re viewing 5 of 12 competitors. Get the full list »

EndoStim Patents

EndoStim Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026232042-A1 Hiatal hernia procedure combined with an implanted electrical stimulation system to treat gastroesophageal reflux disease Pending 01-May-2025
US-12465761-B2 Electrical stimulation system for the treatment of gastrointestinal disorders Active 06-Feb-2018
US-20260131141-A1 Electrical stimulation system for the treatment of gastrointestinal disorders Pending 06-Feb-2018
EP-3606603-A1 Implantable surface electrodes and method of implantation Inactive 06-Apr-2017
US-20190105491-A1 Implantable surface electrodes and method of implantation Active 06-Apr-2017 A61N1/0517
To view EndoStim’s complete patent history, request access »

EndoStim Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoStim Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Integer Holdings PE-Backed Company Minority
Stifel Financial Investment Bank Minority
To view EndoStim’s complete investors history, request access »

EndoStim FAQs

  • When was EndoStim founded?

    EndoStim was founded in 2009.

  • Where is EndoStim headquartered?

    EndoStim is headquartered in Dallas, TX.

  • What is the size of EndoStim?

    EndoStim has 4 total employees.

  • What industry is EndoStim in?

    EndoStim’s primary industry is Therapeutic Devices.

  • Is EndoStim a private or public company?

    EndoStim is a Private company.

  • What is EndoStim’s current revenue?

    The current revenue for EndoStim is .

  • How much funding has EndoStim raised over time?

    EndoStim has raised $73.5M.

  • Who are EndoStim’s investors?

    Integer Holdings and Stifel Financial have invested in EndoStim.

  • Who are EndoStim’s competitors?

    Insightec, Spatz (Therapeutic Devices), Morphic Medical, EndoGastric Solutions, and USGI Medical are some of the 12 competitors of EndoStim.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process